click below
click below
Normal Size Small Size show me how
ID 4
ID 4 (Infectious Diseases 4)
| Generic | Brand | Pharmacologic Category | Common Indication | Key Side Effects | US Boxed Warnings | Other Notes |
|---|---|---|---|---|---|---|
| terbinafine (PO, topical *) | Lamisil | Allylamine antifungal | Onychomycosis | nausea, abdominal pain, diarrhea, elevated hepatic transaminases, headache | ||
| acyclovir (PO, IV) | Zovirax | Antiviral | Herpes simplex virus | nausea, increased hepatic transaminases, crystalluria | vesicant | |
| valacyclovir (PO) | Valtrex | Antiviral | Herpes simplex virus | nausea, increased hepatic transaminases | ||
| fluconazole (PO, IV) | Diflucan | Azole antifungal | Vulvovaginal candidiasis, oropharyngeal candidiasis | nausea, abdominal pain, diarrhea, QTc prolongation, elevated hepatic transaminases | ||
| ketoconazole (PO, topical *) | Nizoral | Azole antifungal | Fungal infections | nausea, abdominal pain, diarrhea, QTc prolongation, increased hepatic transaminases | serious hepatotoxicity, including cases with a fatal outcome or requiring liver transplantation, have occurred; may cause QTc prolongation and drug interactions leading to QTc prolongation | |
| oseltamivir (PO) | Tamiflu | Neuraminidase inhibitor antiviral | Influenza | nausea, vomiting, neuropsychiatric events (i.e., confusion, delirium, hallucinations) in pediatric patients (rare) | ||
| nystatin (PO) | --------- | Polyene antifungal | Oropharyngeal candidiasis | no major side effects | ||
| nystatin (topical) | Nystop | Polyene antifungal | Cutaneous and mucocutaneous fungal infections | burning, itching | only use oral solutions for thrush | |
| micafungin (IV) | Mycamine | Echinocandin antifungal | Invasive candidiasis | no major side effects | ||
| betamethasone and clotrimazole (topical) | Lotrisone | Glucocorticoid and azole antifungal | Cutaneous fungal infections | burning, itching, dryness, skin atrophy | do not use for diaper dermatitis; adrenal suppression with long-term use over large areas of skin | |
| nirmatrelvir + ritonavir (PO) | Paxlovid | Antiviral | COVID-19 | diarrhea, dysgeusia | significant drug interactions; strong CYP3A4 inhibitor | |
| remdesivir (IV) | Veklury | Antiviral | COVID-19 | hyperglycemia, renal impairment | ||
| emtricitabine + tenofovir disoproxil fumarate (PO) | Truvada | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) | HIV, PreP, PEP | decreased bone mineral density, kidney injury, nausea, diarrhea | post treatment acute exacerbation of hepatitis B, risk of drug resistance with use for preexposure prophylaxis | |
| Emtricitabine (NRTI) + tenofovir alafenamide (NRTI) + bictegravir (INSTI) (PO | Biktarvy | Nucleoside/Nucleotide Reverse Transcriptase Inhibitor (NRTI) and Integrase Strand Transfer Inhibitor (INSTI) | HIV | increased serum bilirubin, headache, weight gain, insomnia, diarrhea, nausea | post treatment acute exacerbation of hepatitis B | take oral INSTI’s 2 hours before or 6 hours after products containing calcium, aluminum, magnesium, or iron |